Radiobotics gets FDA clearance for knee OA algorithm

By AuntMinnie.com staff writers

August 31, 2021 -- Artificial intelligence (AI) software developer Radiobotics has secured U.S. Food and Drug Administration 510(k) clearance for RBknee, an AI-based software application designed to aid in the diagnosis of knee osteoarthritis (OA) on radiography.

Suitable for use in orthopedic or radiological settings, RBknee analyzes digital x-rays of knees and identifies common radiographic findings associated with the diagnosis of OA: osteophytes, subchondral sclerosis, and joint space narrowing, according to the Copenhagen, Denmark-based vendor. Its machine-learning algorithms then conclude whether OA is present.

RBknee also measures the joint space width in both compartments of the knee, Radiobotics noted. Radiobotics received the CE Mark in Europe for RBknee earlier this year.


Copyright © 2021 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: